Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia
Matthew S. Davids(Dana-Farber Cancer Institute), Anthony Letai(Dana-Farber Cancer Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Wyndham H. Wilson(National Institutes of Health), Brian J. Lannutti(Fate Therapeutics (United States)), Jing Deng(Guangdong Provincial Center for Disease Control and Prevention), Jennifer R. Brown(Dana-Farber Cancer Institute), Lili Wang(Shanghai Jiao Tong University), Adrian Wiestner(National Institutes of Health)
Cited by 132
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k